Pediatric Nephrology(@Ped_Neph) 's Twitter Profile Photo

Sodium-glucose cotransporter 2 inhibitors (SGLT2is) were developed as glucose-lowering agents. They inhibit glucose & sodium reabsorption in the S1 segment of the proximal tubule. Read this Review of clinical evidence, physiology, & mechanisms of SGLT2is.
link.springer.com/article/10.100…

Sodium-glucose cotransporter 2 inhibitors (SGLT2is) were developed as glucose-lowering agents. They inhibit glucose & sodium reabsorption in the S1 segment of the proximal tubule. Read this Review of clinical evidence, physiology, & mechanisms of SGLT2is.
link.springer.com/article/10.100…
account_circle
Joseph Vassalotti, MD(@Joe_Vassalotti) 's Twitter Profile Photo

Nephrologists should work with and empower PCPs to implement as foundational therapy for CKD.

Summary of current evidence-based indications for SGLT2 inhibition

Nephrologists should work with and empower PCPs to implement #SGLT2i as foundational therapy for CKD.

Summary of current evidence-based indications for SGLT2 inhibition
account_circle
Karen Dwyer(@KarenDwyer12) 's Twitter Profile Photo

Mmmm foundational is lifestyle advice followed by pharmacotherapy. Drugs won't work without positive health behaviour change......signed a flozinator.

account_circle
Roberto Pecoits-Filho(@pecoitsfilho) 's Twitter Profile Photo

🇧🇷📣📣 Just a few minutes ago, the Brazilian MoH incorporated an SGLT2i into one of the largest public systems in the world for the treatment of . SGLTi free of cost for all!! A huge step for millions of Brazilian people with kidney disease.

account_circle